TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07038473: Islet Autoantibody Early Detection in At-risk Children/Adolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries

Sponsor: Sanofi · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 3500 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07038473 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07038473 Rescue Dossier →